Oxcarbazepine

Mood Stabilizer, Anticonvulsant

Oxcarbazepine

Trileptal

Experience

👥 No personal reports yet

⚕ No clinical reports yet

Log in to add your own experience.

Problems

No problems yet. Be the first to suggest one.

+ Add a problem

Titration strategies

No titration strategies yet. Be the first to suggest one.

+ Add a titration strategy

Effects

No effects listed yet. Be the first to suggest one.

+ Add an effect

Interactions

Pharmacogenomic + mechanism interactions2 edges

Pharmacogenomic guideline recommendationsCPIC and Dutch Pharmacogenetics Working Group clinical guidelines

Variant:hla-b 1502 pos contraindication CPIC A 90 / 100Rate

CPIC rec 8094683 [Strong]: If patient is oxcarbazepine-naïve, do not use oxcarbazepine. CPIC pair-level A (HLA-A, HLA-B and Carbamazepine and Oxcarbazepine) [PMID 29392710]

Variant:hla-b 1502 pos risk hypersensitivity CPIC A 20 / 100Rate

CPIC rec 8094685 [Optional]: The latency period for drug-induced SJS/TEN is short with continuous dosing and adherence to therapy (~4-28 days), and cases usually occur within three months of dosing; therefore, if the patient has previously used oxcarbazepine consistently for longer than three months without incidence of cutaneous adverse reactions, cautiously consider use of oxcarbazepine in the future. CPIC pair-level A (HLA-A, HLA-B and Carbamazepine and Oxcarbazepine) [PMID 29392710]

Patient experience

No patient-experience reports yet.

+ Add an interaction

Relevant anecdote

No anecdotes yet. Share a relevant one.

+ Add an anecdote

Relevant Literature

No literature entries yet.

Log in to submit relevant literature.

Pharmacy

Common uses

Classification(s)

Classes

Mood Stabilizer, Anticonvulsant

Pharmacology

Purported mechanism

Sodium channel blocker

Pharmacopedia is intended for reference. Nothing here is advice. In an emergency call 911; US Poison Control 1-800-222-1222. See the full disclaimer.